4.2 Article

Diurnal variation of phenylalanine concentrations in tyrosinaemia type 1: should we be concerned?

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients

A. Masurel-Paulet et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2008)

Article Genetics & Heredity

The genetic tyrosinemias

CR Scott

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2006)

Article Pharmacology & Pharmacy

Nitisinone in the treatment of hereditary tyrosinaemia type 1

PJ McKiernan

DRUGS (2006)

Article Endocrinology & Metabolism

A new, low-volume protein substitute for teenagers and adults with phenylketonuria

A MacDonald et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2004)

Article Endocrinology & Metabolism

Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I

M Al-Dhalimy et al.

MOLECULAR GENETICS AND METABOLISM (2002)

Article Endocrinology & Metabolism

Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia

CJ Wilson et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2000)